期刊文献+

冠状动脉钙化病变对药物洗脱支架植入后内膜增生的作用 被引量:2

Impact of calcified lesion on the intimal hyperplasia after implantation of drug eluting stent: an intravascular ultrasound study
原文传递
导出
摘要 目的利用血管内超声观察冠状动脉钙化病变对药物洗脱支架植入后内膜增生的作用。方法对97例(99处病变)冠心病患者在药物洗脱支架植入后8个月利用血管内超声(IVUS)测定支架近端、支架远端和支架内管腔最小处血管段外弹力膜(EEM)横截面积(CSA),支架内CSA,管腔CSA,新生内膜面积,支架最大直径及最小直径,并推算支架对称指数。根据IVUS检测血管钙化的情况将支架植入段血管分为钙化病变组和非钙化病变组,观察钙化病变对支架植入后内膜增生的作用。结果99处病变中有14例支架内内膜增生。与非钙化组患者比较,钙化病变组支架植入后支架两端支架内CSA相似:支架近端为(7·30±1·94)mm2和(6·58±1·96)mm2;支架远端为(6·74±2·02)mm2和(6·14±1·82)mm2。但支架内最小CSA明显减小[(6·10±1·87)mm2和(4·97±1·51)mm2,P<0·05]且对称性较差(对称指数0·92±0·07和0·87±0·09,P<0·05),但内膜面积反而显著减少(0·53±1·50)mm2与(0·02±0·20)mm2。结论冠状动脉药物洗脱支架治疗钙化病变支架扩张程度和对称性均较差,但是与非钙化病变患者比较,内膜增生反而减少。 Objective To investigate the impact of calcified lesion on the intimal hyperplasia after implantation of drug eluting stent. Methods Ninety-nine rapamycin-eluting stents were implanted into the left anterior descending branches of coronary artery of 97 patients with 99 lesions. Eight months later intravascular ultrasound (IVUS) was used to examine the cross section area (CSA) of the external elastic membrane (EEM) at the stent inlet and at the stent outlet, in-stent CSA, CSA of the lumen, area of neointima ( in-stent area minus lumen CSA), the maximum and minimum diameters of stent, and symmetry index of stent ( minimal diameter of stent/maximum diameter of stent ). Results Forty-one lesions were calcified and 58 non-calcified. Fourteen of the 99 lesions in the 97 patients developed intimal hyperplasia. The inlet stent CSA of the calcified group was (7.30 ± 1.94) mm^2, similar to that of the non-calcified group (6.58 ± 1.96) mm^2; the outlet CSA of the calcified group was (6.74 ±2.02) mm^2, similar to that of the non-calcified group (6.14 ± 1.82) mm^2. The minimum stent CSA of the calcified group was (4.97 ± 1.51 ) mm^2, significantly smaller than that of the non-calcified group ( 6. 10 ± 1.87 ) mm^2 ( P 〈 0.05 ) , the symmetry index of the calcified group was 0.92 ± 0.07, significantly lower than that of the non-calcified group (0.92 ± 0.07, P 〈 0.05 ) , and the intimal area of the calcified group was ( 0.02 ± 0. 20) mm^2, significantly smaller than that of the non-calcified group ( 0.53 ± 1.50 ) mm^2 ( P 〈 0.05 ). Conclusion Drug eluting stent implantation in the patients with calcified lesions has a less stent CSA and poor symmetry, and less intimal hyperplasia compared with those in the non-calcified lesions.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第16期1118-1121,共4页 National Medical Journal of China
关键词 冠状动脉疾病 药物洗脱支架 血管内膜 超声检查 介入性 冠状血管造影术 冠状动脉钙化病变 内膜增生 Coronary diseases Drug eluting stents Tunica intima Uhrasonography, interventional Coronary angiography
  • 相关文献

参考文献14

  • 1Sousa JE,Costa MA,Abizaid AC,et al.Sustained suppression of neointimal proliferation by sirolimus-eluting stents:one-year angiographic and intravascular ultrasound follow-up.Circulation,2001,104:2007-2011.
  • 2Regar E,Serruys PW,Bode C,et al.Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL):sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.Circulation,2002,106:1949-1956.
  • 3Moses JW,Leon MB,Popma JJ,et al.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl J Med,2003,349:1315-1323.
  • 4Lemos PA,Hoye A,Goedhart D,et al.Clinical,angiographic,and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients:an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study.Circulation,2004,109:1366-1370.
  • 5Stone GW,St.Goar F,Fitzgerald P,et al.The optimal stent implantation trial:final core lab angiographic and ultrasound analysis (abstract).J Am Coll Cardiol,1997;29:369.
  • 6Hoffmann R,Mintz GS,Pichard AD,Intimal hyperplasia thickness at follow-up is independent of stent size:a serial intravascular ultrasound study.Am J Cardiol,1998,82:1168-1172.
  • 7Robert D S,Mark F.The Manual of Interventional Cardiology,3rd Edition.Philadelphia:Physician's Press,2001.10-18.
  • 8Sonoda S,Morino Y,Ako J,et al.An optimal diagnostic threshold of minimum stent area to predict long-term stent patency following sirolimus-eluting stent implantation:serial intravascular ultrasound analysis from the SIRIUS Trial.J Am Coll Cardiol,2003,41:80.
  • 9Takebayashi H,Mintz GS,Carlier SG.Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.Circulation.,2004,110:3430-3434.
  • 10Diver DJ,Bier JD,Ferreira PE,et al.Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial).Am J Cardiol.,1994,74:531-537.

同被引文献4

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部